- Weitere Titel
-
Entwicklung von Anti-TNF-Antikörper-Gold-Nanopartikeln
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Würzburg, Universität Würzburg, Dissertation, 2023
- Schlagwort
-
Antikörper
Gold
Nanopartikel
Nanopartikel
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2024
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.25972/OPUS-34921
- URN
-
urn:nbn:de:bvb:20-opus-349212
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aido, Ahmed
- Wajant, Harald
- Universität Würzburg
Entstanden
- 2024
Ähnliche Objekte (12)
Monitoring of anti-TNF biological treatments
Stopping Anti-TNF in CD Remitters: Cons
Anti-TNF, a magic bullet in cancer immunotherapy?
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease Patients
Der molekulare Wirkmechanismus der anti-TNF Antikörper bei chronisch entzündlichen Darmerkrankungen
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
A review of ocular adverse events of biological anti-TNF drugs
Monitoring of anti-TNF biological treatments
Stopping Anti-TNF in CD Remitters: Cons
Anti-TNF, a magic bullet in cancer immunotherapy?
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease Patients
Der molekulare Wirkmechanismus der anti-TNF Antikörper bei chronisch entzündlichen Darmerkrankungen
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
A review of ocular adverse events of biological anti-TNF drugs
Monitoring of anti-TNF biological treatments
Stopping Anti-TNF in CD Remitters: Cons
Anti-TNF, a magic bullet in cancer immunotherapy?
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease Patients
Der molekulare Wirkmechanismus der anti-TNF Antikörper bei chronisch entzündlichen Darmerkrankungen
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients